Shanghai MicroPort Endovascular MedTech Past Earnings Performance
Past criteria checks 4/6
Shanghai MicroPort Endovascular MedTech has been growing earnings at an average annual rate of 28.1%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 28.1% per year. Shanghai MicroPort Endovascular MedTech's return on equity is 16.6%, and it has net margins of 51.8%.
Key information
28.1%
Earnings growth rate
25.2%
EPS growth rate
| Medical Equipment Industry Growth | 16.0% |
| Revenue growth rate | 28.1% |
| Return on equity | 16.6% |
| Net Margin | 51.8% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Shanghai MicroPort Endovascular MedTech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,268 | 657 | 197 | 126 |
| 30 Jun 24 | 1,353 | 616 | 195 | 145 |
| 31 Mar 24 | 1,260 | 552 | 190 | 160 |
| 31 Dec 23 | 1,187 | 492 | 187 | 173 |
| 30 Sep 23 | 1,121 | 444 | 193 | 167 |
| 30 Jun 23 | 1,059 | 421 | 191 | 161 |
| 31 Mar 23 | 924 | 358 | 160 | 139 |
| 31 Dec 22 | 897 | 357 | 153 | 138 |
| 30 Sep 22 | 839 | 367 | 125 | 123 |
| 30 Jun 22 | 781 | 346 | 117 | 114 |
| 31 Mar 22 | 745 | 338 | 113 | 115 |
| 31 Dec 21 | 685 | 316 | 105 | 102 |
| 30 Sep 21 | 652 | 302 | 97 | 99 |
| 30 Jun 21 | 618 | 279 | 92 | 91 |
| 31 Mar 21 | 569 | 257 | 90 | 85 |
| 31 Dec 20 | 470 | 215 | 79 | 73 |
| 30 Sep 20 | 414 | 192 | 76 | 61 |
| 30 Jun 20 | 377 | 177 | 72 | 53 |
| 31 Mar 20 | 341 | 156 | 71 | 51 |
| 31 Dec 19 | 334 | 142 | 71 | 50 |
| 30 Sep 19 | 306 | 127 | 65 | 42 |
| 30 Jun 19 | 282 | 115 | 60 | 37 |
| 31 Mar 19 | 257 | 103 | 66 | 37 |
| 31 Dec 18 | 231 | 91 | 53 | 30 |
| 31 Dec 17 | 165 | 63 | 32 | 20 |
| 31 Dec 16 | 125 | 41 | 28 | 20 |
Quality Earnings: 688016 has a high level of non-cash earnings.
Growing Profit Margin: 688016's current net profit margins (51.8%) are higher than last year (39.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688016's earnings have grown significantly by 28.1% per year over the past 5 years.
Accelerating Growth: 688016's earnings growth over the past year (47.9%) exceeds its 5-year average (28.1% per year).
Earnings vs Industry: 688016 earnings growth over the past year (47.9%) exceeded the Medical Equipment industry -8.8%.
Return on Equity
High ROE: 688016's Return on Equity (16.6%) is considered low.